The positions in the table below reflect the Merck Sharp and Dohme B.V. (MSD BV Haarlem)'s position overall, domestically, within their sector, and in various subject areas based on their Share. Each ...

Merck Sharp & Dohme LLC has prepared and tested triggering receptor expressed on myeloid cells 2 (TREM2) agonists reported to be useful for the treatment of Alzheimer’s disease and neurodegeneration.

Merck Sharp & Dohme LLC has identified NLRP3 inflammasome inhibitors reported to be useful for the treatment of atherosclerosis, nonalcoholic or metabolic dysfunction-associated steatohepatitis ...

The outbreak of the COVID-19 pandemic demonstrated the need to rapidly develop, produce and distribute large quantities of ...

Daiichi Sankyo Company (($DSKYF)) announced an update on their ongoing clinical study. Study Overview: Daiichi Sankyo Company, in collaboration ...

Daiichi Sankyo Company (($DSKYF)) announced an update on their ongoing clinical study. Study Overview: Daiichi Sankyo, in collaboration with Merck ...

Dr. Reddy’s (RDY) Laboratories and Senores Pharmaceuticals announced the launch of Ivermectin Tablets USP, 3 mg, which is bioequivalent and therapeutically equivalent to STROMECTOL Tablets of Merck ...

Merck filed a trademark lawsuit against Central Rx 1 on Oct. 22 in New York Eastern District Court. The complaint, filed by Covington & Burling, alleges the defendant sold counterfeit versions of the ...

(RTTNews) - Halozyme Therapeutics (HALO) filed a patent infringement lawsuit against Merck Sharp & Dohme Corp. in U.S. District Court in New Jersey. Halozyme believes the subcutaneous formulation of ...

The benefit of the addition of perioperative pembrolizumab to standard care with surgery and adjuvant therapy for patients with locally advanced head and neck squamous-cell carcinoma (HNSCC) is ...

Article ‘Count’ and ‘Share’ for Merck Sharp and Dohme B.V. (MSD BV Haarlem) based on listed parameters only. The articles listed below published by authors from Merck Sharp and Dohme B.V. (MSD BV ...